IMMX
Immix Biopharma, Inc.
NASDAQ · Healthcare · Biotechnology · US
$13.91
+0.58%Aug 25, 2026, 07:47 UTC
Immix Biopharma's stock reached a new 52-week high of $13.80 during mid-day trading on Tuesday, with the last trade at $13.61 and volume of 1,414,936 shares.
Source:Jul 21, 2026, 17:51 UTC
The Portnoy Law Firm initiated an investigation into Immix Biopharma for possible securities fraud and may file a class action on behalf of investors.